» Articles » PMID: 37621819

Metastatic Lung Adenocarcinoma: A Case of Unusual Presentation With a Skull Mass

Overview
Journal Cureus
Date 2023 Aug 25
PMID 37621819
Authors
Affiliations
Soon will be listed here.
Abstract

This case report describes an uncommon presentation of lung adenocarcinoma, which appeared as a skull mass. While not the first reported case in medical literature, it is still a rare occurrence for lung adenocarcinoma to present in this manner. This report focuses on the clinical presentation and treatment of an elderly male patient who had a progressively enlarging and painful skull mass. The initial imaging revealed an about 5 cm soft tissue mass at the dorsal midline of the parietal-occipital bone. Subsequent imaging identified a lung mass, and a biopsy of the skull bone confirmed that the mass was metastatic adenocarcinoma originating from the lung. For treatment, the patient underwent occipital partial resection of the mass, followed by wire mesh cranioplasty. Chemotherapy and external beam radiotherapy were administered to alleviate symptoms and control the spread of cancer. Lung carcinoma with distant metastasis is generally associated with a poorer prognosis. However, some supporting data suggest that early detection and aggressive management play crucial roles in preventing further metastasis and improving the patient's quality of life and overall survival rate. Skull bone metastasis from lung cancer is indeed a rare phenomenon, and cases like these contribute valuable knowledge to the field. By reporting such cases, healthcare professionals can gain a better understanding of the clinical manifestations, diagnostic challenges, and appropriate management strategies for these uncommon occurrences. This case report underscores the significance of maintaining a high index of suspicion and utilizing a multimodality approach to diagnose rare instances of calvarial metastasis.

Citing Articles

Single-molecule targeted therapy shrinks lung lesions and improves bone metastases: A case report.

Wei J, Hu B, Fang H, Zhang F, Wang P Medicine (Baltimore). 2024; 103(29):e38874.

PMID: 39029067 PMC: 11398788. DOI: 10.1097/MD.0000000000038874.

References
1.
Sun J, Ahn J, Lee S, Kim J, Lee J, Park Y . Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases. Lung Cancer. 2010; 71(1):89-93. DOI: 10.1016/j.lungcan.2010.04.003. View

2.
Guo X, Ma W, Wu H, Xu Y, Wang D, Zhang S . Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China. BMC Cancer. 2021; 21(1):613. PMC: 8152068. DOI: 10.1186/s12885-021-08379-2. View

3.
Su Y, Hsu Y, Chai C . Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma. Kaohsiung J Med Sci. 2006; 22(1):14-9. DOI: 10.1016/S1607-551X(09)70214-1. View

4.
Gurel B, Ali T, Montgomery E, Begum S, Hicks J, Goggins M . NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol. 2010; 34(8):1097-105. PMC: 3072223. DOI: 10.1097/PAS.0b013e3181e6cbf3. View

5.
Ugga L, Cuocolo R, Cocozza S, Ponsiglione A, Stanzione A, Chianca V . Spectrum of lytic lesions of the skull: a pictorial essay. Insights Imaging. 2018; 9(5):845-856. PMC: 6206388. DOI: 10.1007/s13244-018-0653-y. View